false
Catalog
2024 World Conference on Lung Cancer (WCLC) - ePos ...
EP.07B.09 Lymph Node Evaluation for Stage Cia Non- ...
EP.07B.09 Lymph Node Evaluation for Stage Cia Non-Small Cell Lung Cancer: Findings from a Single Institution
Back to course
Pdf Summary
The study, conducted by Zijia Chen and colleagues at the Lung Cancer Center, West China Hospital, focuses on lymph node evaluation in patients with stage cIA non-small cell lung cancer (NSCLC). It aims to clarify uncertainties regarding lymph node dissection protocols for these patients. Using data from a population-based registry and a single institution, this retrospective study analyzed 556 patients diagnosed between August 2014 and November 2018. The median age of participants was 59 years, and most were diagnosed with adenocarcinoma.<br /><br />Key findings indicate that examining more lymph nodes (ELNs) is associated with differences in outcomes. A significant association was found between more ELNs and recurrence-free survival (RFS), although simply increasing ELN numbers did not always correlate with improved disease-free survival (DFS) in patients with positive ELNs. Important is the composition of the tumor; patients with a solid component exceeding 50% of the tumor benefited more from lymph node dissection if the number of ELNs ranged from 8 to 23. In contrast, no notable benefit was observed for those with less than 50% solid components.<br /><br />The study concludes that while sufficient ELN evaluation is vital for accurate patient staging and improving prognosis, simply increasing ELNs may not better DFS for those with lymph node-positive status. For these patients, postoperative treatment should be considered. This research contributes to the ongoing discussion about optimizing surgical protocols and treatment pathways in NSCLC, emphasizing tailored approaches based on tumor characteristics and lymph node involvement.
Asset Subtitle
Zijia Chen
Meta Tag
Speaker
Zijia Chen
Topic
Early-Stage Non-small Cell Lung Cancer
Keywords
lymph node evaluation
stage cIA NSCLC
lymph node dissection
recurrence-free survival
disease-free survival
adenocarcinoma
ELN evaluation
tumor characteristics
surgical protocols
postoperative treatment
×
Please select your language
1
English